- Home
- PRLD vs RMTI Comparison
PRLD vs RMTI Comparison
Compare PRLD & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- RMTI
- Stock Information
- Founded
- PRLD 2016
- RMTI 1994
- Country
- PRLD United States
- RMTI United States
- Employees
- PRLD N/A
- RMTI N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- PRLD Health Care
- RMTI Health Care
- Exchange
- PRLD Nasdaq
- RMTI Nasdaq
- Market Cap
- PRLD 73.7M
- RMTI 71.1M
- IPO Year
- PRLD 2020
- RMTI 1998
- Fundamental
- Price
- PRLD $0.87
- RMTI $1.77
- Analyst Decision
- PRLD Strong Buy
- RMTI Strong Buy
- Analyst Count
- PRLD 2
- RMTI 2
- Target Price
- PRLD $4.50
- RMTI $6.00
- AVG Volume (30 Days)
- PRLD 200.4K
- RMTI 266.2K
- Earning Date
- PRLD 03-04-2025
- RMTI 03-20-2025
- Dividend Yield
- PRLD N/A
- RMTI N/A
- EPS Growth
- PRLD N/A
- RMTI N/A
- EPS
- PRLD N/A
- RMTI N/A
- Revenue
- PRLD $3,000,000.00
- RMTI $98,917,000.00
- Revenue This Year
- PRLD N/A
- RMTI $22.58
- Revenue Next Year
- PRLD N/A
- RMTI N/A
- P/E Ratio
- PRLD N/A
- RMTI N/A
- Revenue Growth
- PRLD N/A
- RMTI 22.37
- 52 Week Low
- PRLD $0.80
- RMTI $1.23
- 52 Week High
- PRLD $6.80
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- PRLD 37.59
- RMTI 33.96
- Support Level
- PRLD $0.87
- RMTI $1.75
- Resistance Level
- PRLD $1.01
- RMTI $1.97
- Average True Range (ATR)
- PRLD 0.08
- RMTI 0.10
- MACD
- PRLD -0.02
- RMTI -0.01
- Stochastic Oscillator
- PRLD 0.90
- RMTI 5.71
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.